2023 Publications

Anti-fibrotic strategies and pulmonary fibrosis. View article. Gunatilaka A, Zhang S, Tan WSD, and Stewart AG. 2023. Advances in Pharmacology.

An integrated cell atlas of the lung in health and disease. View article. Sikkema, L., Ramírez-Suástegui, C., Strobl, D.C. et al. 2023. Nature Medicine.

Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019. View article. GBD 2019 Chronic Respiratory Diseases Collaborators. 2023. eClinicalMedicine. 

Football and respiratory medicine—Time to start kicking goals. View article. Smallwood N. 2023. Respirology.

Long-term exposure to low concentrations of air pollution and decline in lung function in people with idiopathic pulmonary fibrosis: Evidence from Australia. View article. Zheng Q.; Cox I.A.; Leigh L.; de Graaff B.; Johnston F.H.; Corte T.J.; Knibbs L.D.; Otahal P.; Navaratnam V.; Campbell J.A.; Glaspole I.; Moodley Y.; Hopkins P.; Mackintosh J.A.; Ahmad H.; Walters E.H.; Palmer A.J. 2023. Respirology.

Lockdown as the mother of invention: disruptive technology in a disrupted time. View article. Holland A.E.; Glaspole I. 2023. The Lancet Respiratory Medicine.

Novel diagnostic techniques in interstitial lung disease. View article. Glenn L.M.; Troy L.K.; Corte T.J. 2023. Frontiers in Medicine.

Prescribing walking training in interstitial lung disease from the 6-minute walk test. View article. Nakazawa A.; Dowman L.M.; Cox N.S.; Brazzale D.J.; McDonald C.F.; Hill C.J.; Lee A.; Holland A.E. 2023. Physiotherapy Theory and Practice.

The impact of air pollution on interstitial lung disease: a systematic review and meta-analysis. View article. Lan D.; Fermoyle C.C.; Troy L.K.; Knibbs L.D.; Corte T.J. 2023. Frontiers in Medicine.

Missing out on effective care in idiopathic pulmonary fibrosis: Racial inequality in access to anti-fibrotic therapy. View article. Pascoe A.; Smallwood N. 2023. Respirology.

Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants. View article. Peljto A.L.; Blumhagen R.Z.; Walts A.D.; Cardwell J.; Powers J.; Corte T.J.; Dickinson J.L.; Glaspole I, et al. 2023. American Journal of Respiratory and Critical Care Medicine.

A Methodological Approach to Identify Natural Compounds with Antifibrotic Activity and the Potential to Treat Pulmonary Fibrosis Using Single-Cell Sequencing and Primary Human Lung Macrophages. View article. Apte S.H.; Groves P.L.; Tan M.E.; Lutzky V.P.; de Silva T.; Monteith J.N.; Yerkovich S.T.; O’Sullivan B.J.; Davis R.A.; Chambers D.C. 2023. International Journal of Molecular Sciences.

The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study. View article. Cox I.A.; de Graaff B.; Ahmed H.; Campbell J.; Otahal P.; Corte T.J.; Moodley Y.; Goh N.; Hopkins P.; Macansh S.; Walters E.H.; Palmer A.J. 2023. European Journal of Health Economics.

Advanced models for respiratory disease and drug studies. View article. Shrestha J.; Paudel K.R.; Nazari H.; Dharwal V.; Bazaz S.R.; Johansen M.D.; Dua K.; Hansbro P.M.; Warkiani M.E. 2023. Medicinal Research Reviews.

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. View article. Solomon J.J.; Danoff S.K.; Woodhead F.A.; Hurwitz S.; Maurer R.; Glaspole I. et al. The Lancet Respiratory Medicine.

Palliative care in COPD and ILD: a call for action. View article. Wijsenbeek M.; Valenzuela C.; Holland A. 2023. European Respiratory Journal.

Holistic management of patients with progressive pulmonary fibrosis. View article.  Oliveira A.; Fabbri G.; Gille T.; Bargagli E.; Duchemann B.; Evans R.; Pinnock H.; Holland A.E.; Renzoni E.; Ekström M.; Jones S.; Wijsenbeek M.; Dinh-Xuan A.T.; Vagheggini G. 2023. Breathe.

Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease An Official American Thoracic Society Clinical Practice Guideline. View article. Rochester C.L.; Alison J.A.; Carlin B.; Jenkins A.R.; Cox N.S.; Bauldoff G.; Bhatt S.P.; Bourbeau J.; Burtin C.; Camp P.G.; Cascino T.M.; Koppel G.A.D.; Garvey C.; Goldstein R.; Harris D.; Houchen-Wolloff L.; Limberg T.; Lindenauer P.K.; Moy M.L.; Ryerson C.J.; Singh S.J.; Steiner M.; Tappan R.S.; Yohannes A.M.; Holland A.E. 2023. American Journal of Respiratory and Critical Care Medicine

Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management. View article. Olsson K.M.; Corte T.J.; Kamp J.C.; Montani D.; Nathan S.D.; Neubert L.; Price L.C.; Kiely D.G. 2023. The Lancet Respiratory Medicine.

Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases. View article. Chan Y.; Raju Allam V.S.R.; Paudel K.R.; Singh S.K.; Gulati M.; Dhanasekaran M.; Gupta P.K.; Jha N.K.; Devkota H.P.; Gupta G.; Hansbro P.M.; Oliver B.G.G.; Chellappan D.K.; Dua K. 2023. Critical Reviews in Food Science and Nutrition

Perceived Autonomy Support in Telerehabilitation by People With Chronic Respiratory Disease: A Mixed Methods Study. View article. Cox N.S.; Lee J.Y.T.; McDonald C.F.; Mahal A.; Alison J.A.; Wootton R.; Hill C.J.; Zanaboni P.; O’Halloran P.; Bondarenko J.; Macdonald H.; Barker K.; Crute H.; Mellerick C.; Wageck B.; Boursinos H.; Lahham A.; Nichols A.; Czupryn P.; Corbett M.; Handley E.; Burge A.T.; Holland A.E. 2023. Chest.

Occupational interstitial lung diseases. View article. Spagnolo P.; Ryerson C.J.; Guler S.; Feary J.; Churg A.; Fontenot A.P.; Piciucchi S.; Udwadia Z.; Corte T.J.; Wuyts W.A.; Johannson K.A.; Cottin V. 2023. Journal of Internal Medicine.

Self-management interventions for people with pulmonary fibrosis: a scoping review. View article. Lee JYT, Tikellis G, Dowman L, Jones AW, Hoffman M, Mellerick CR, Malaguti C, Khor YH, Holland AE. 2023. European Respiratory Review.

Barriers to and facilitators of the use of oxygen therapy in people living with an interstitial lung disease: a systematic review of qualitative evidence. View article. Tikellis G, Hoffman M, Mellerick C, Burge AT, Holland AE. 2023. European Respiratory Review.

Endothelial-to-mesenchymal transition: a precursor to pulmonary arterial remodelling in patients with idiopathic pulmonary fibrosis. View article. Gaikwad AV, Lu W….Eapen MS, Sohal SS. 2023. ERJ Open Research. 

The influence of immortal time bias in observational studies examining associations of antifibrotic therapy with survival in idiopathic pulmonary fibrosis: A simulation study. View article. Zheng Q, Otahal P, Cox IA, et al. 2023. Frontiers in Medicine. 

Treatable traits: a comprehensive precision medicine in interstitial lung disease. View article. Khor, YH, Cottin, V, Holland, AE et al. 2023. European Respiratory Review.

Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D. View article. Cox IA, Campbell J, de Graaff B, Otahal P, Corte TJ, Moodley Y, Hopkins P, Macansh S, Walters EH, Palmer AJ. 2023. Quality of Life Research.

Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung disease. View article. Wong AW, Sun H, Cox IA, Fisher JH, Khalil N, Johannson KA, Marcoux V, Assayag D, Manganas H, Kolb M, Palmer AJ, de Graaff B, Walters EH, Hopkins P, Zappala C, Goh NS, Moodley Y, Navaratnam V, Corte TJ, Ryerson CJ, Zhang W. 2023. PLoS One. 

Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaire. View article. Barnes H, Chambers D, Grainge C, Corte TJ, Bastiampillai S, Frenkel S, Westall G, Collard H, Glaspole I. 2023. Respirology.

Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients. View article. Lucas, S.E.M., Raspin, K., Mackintosh, J., I. Glaspole, Reynolds, P.N., Chia, C., Grainge, C., Kendall, P., Troy, L., Schwartz, D.A., Wood-Baker, R., Walsh, S.L.F., Moodley, Y., Robertson, J., Macansh, S., Walters, E.H., Chambers, D., Corte, T.J., Dickinson, J.L. 2023. Pulmonology.

Understanding patient experience of chronic cough in interstitial lung disease. View article. Mann, J.M.V., Holland, A.E., Goh, N.S.L., Khor, Y.H. 2023. ERJ Open Research.

“Understanding the telehealth experience of care by people with ILD during the COVID-19 pandemic: what have we learnt?” View article. Tikellis, G., Corte, T., Glaspole, I.N. et al. 2023. BMC Pulmonary Medicine.

Machine learning in radiology: the new frontier in interstitial lung diseases. View article. Barnes H, Humphries SM, George PM, Assayag D, Glaspole I, Mackintosh JA et al. Lancet Digit Health.

Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial. View article. West A, Chaudhuri N, Barczyk A, Wilsher ML, Hopkins P, Glaspole I, Corte TJ, (…) Montgomery AB. 2023. Thorax. 

A composite serum biomarker index for the diagnosis of systemic sclerosis interstitial lung disease: a multicentre, observational, cohort study. View article. Jee, A.S., Stewart, I., Youssef, P., Adelstein, S., Lai, D., Hua, S., Stevens, W., Proudman, S., Ngian, G.-S., Glaspole, I.N., Moodley, Y.P., Bleasel, J.F., Macansh, S., Nikpour, M., Sahhar, J., Corte, T.J. 2023. Arthritis Rheumatology.

Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia. View article. Assayag D, Adegunsoye A, Sheehy R, Morisset J, Khalil N, Johannson KA, Marcoux V, Kolb M, Fisher JH, Manganas H, Wrobel J, Wilsher M, De Boer S, Mackintosh J, Chambers DC, Glaspole I, Keir GJ, Lee CT, Jablonski R, Vij R, Strek ME, Corte TJ, Ryerson CJ. 2023. Chest.

The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument. View article. Zheng Q, Cox IA, de Graaff B, Campbell JA, Corte TJ, Glaspole I, Navaratnam V, Hopkins P, Zappala C, Ahmad H, Zhao T, Macansh S, Walters EH, Palmer AJ. 2023. Quality of Life Research.